Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (32)
R. Bonassi Machado, L. de Melo Pompei, E. A. P. Nahas, J. Nahas-Neto, L. da Costa-Paiva, S. Y. O. Del Debbio, M. Badalotti, M. C. O. Wender & A. M. Cruz. (2023) Efficacy and safety of ultra-low-dose estradiol and norethisterone in postmenopausal Brazilian women. Climacteric 26:4, pages 401-407.
Read now
Read now
Sumika Matsui, Toshiyuki Yasui, Kana Kasai, Kaoru Keyama, Kanako Yoshida, Takeshi Kato, Hirokazu Uemura, Akira Kuwahara, Toshiya Matsuzaki & Minoru Irahara. (2017) Sex hormone-binding globulin and antithrombin III activity in women with oral ultra-low-dose estradiol. Journal of Obstetrics and Gynaecology 37:5, pages 627-632.
Read now
Read now
Zhilan Yang, Ying Hu, Jing Zhang, Liangzhi Xu, Rujun Zeng & Deying Kang. (2017) Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis. Gynecological Endocrinology 33:2, pages 87-92.
Read now
Read now
L-å. Mattsson, H. e. Ipsen, C-j. Granqvist & M. Kokot-Kierepa. (2015) Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy. Climacteric 18:3, pages 419-425.
Read now
Read now
P. Stute, H.-G. Becker, J. Bitzer, D. Chatsiproios, F. Luzuy, M. von Wolff, D. Wunder & M. Birkhäuser. (2015) Ultra-low dose – new approaches in menopausal hormone therapy. Climacteric 18:2, pages 182-186.
Read now
Read now
S. Shapiro, T. J. de Villiers, A. Pines, D. W. Sturdee, R. J. Baber, N. Panay, J. C. Stevenson, A. O Mueck & H. G. Burger. (2014) Risks and benefits of hormone therapy: has medical dogma now been overturned?. Climacteric 17:3, pages 215-222.
Read now
Read now
. (2014) Abstracts of Posters. Climacteric 17:sup1, pages 48-108.
Read now
Read now
S. Matsui, T. Yasui, A. Tani, T. Kato, H. Uemura, A. Kuwahara, T. Matsuzaki, K. Arisawa & M. Irahara. (2014) Effect of ultra-low-dose estradiol and dydrogesterone on arterial stiffness in postmenopausal women. Climacteric 17:2, pages 191-196.
Read now
Read now
D. W. Sturdee. (2013) Are progestins really necessary as part of a combined HRT regimen?. Climacteric 16:sup1, pages 79-84.
Read now
Read now
Lisa A Chism. (2012) Overcoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophy. International Journal of Women's Health 4, pages 551-557.
Read now
Read now
Nick Panay & Anna Fenton. (2012) Does HRT increase the risk of breast cancer? Don't forget the menopausal woman!. Climacteric 15:2, pages 103-104.
Read now
Read now
Nick Panay & Anna Fenton. (2011) Alternative regimens for endometrial protection – where are we now?. Climacteric 14:6, pages 607-608.
Read now
Read now
D. F. Archer, D. W. Sturdee, R. Baber, T. J. de Villiers, A. Pines, R. R. Freedman, A. Gompel, M. Hickey, M. S. Hunter, R. A. Lobo, M. A. Lumsden, A. H. MacLennan, P. Maki, S. Palacios, D. Shah, P. Villaseca & M. Warren. (2011) Menopausal hot flushes and night sweats: where are we now?. Climacteric 14:5, pages 515-528.
Read now
Read now
Nick Panay & Anna Fenton. (2011) Has the time for the definitive, randomized, placebo-controlled HRT trial arrived?. Climacteric 14:2, pages 195-196.
Read now
Read now
H. Zang, H. Shi & L. Speroff. (2010) Low-dose hormone therapy in postmenopausal women in China. Climacteric 13:6, pages 544-552.
Read now
Read now
P. Tuomikoski, T. S. Mikkola, M. J. Tikkanen & O. Ylikorkala. (2010) Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy. Climacteric 13:5, pages 457-466.
Read now
Read now
Pauliina Tuomikoski, Petri Haapalahti, Seppo Sarna, Olavi Ylikorkala & Tomi S. Mikkola. (2010) Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy. Annals of Medicine 42:5, pages 334-343.
Read now
Read now
Nick Panay & Anna Fenton. (2010) Bioidentical hormones: what is all the hype about?. Climacteric 13:1, pages 1-3.
Read now
Read now
G. Samsioe & J. Hruska. (2010) Optimal tolerability of ultra-low-dose continuous combined 17β-estradiol and norethisterone acetate: laboratory and safety results. Climacteric 13:1, pages 34-44.
Read now
Read now
Pauliina Tuomikoski, Petri Haapalahti, Olavi Ylikorkala & Tomi S. Mikkola. (2010) Vasomotor hot flushes and 24-hour ambulatory blood pressure in recently post-menopausal women. Annals of Medicine 42:3, pages 216-222.
Read now
Read now
Wen Shen & Vered Stearns. (2009) Treatment strategies for hot flushes. Expert Opinion on Pharmacotherapy 10:7, pages 1133-1144.
Read now
Read now
Anna Fenton & Nick Panay. (2009) New trends in hormone therapy. Climacteric 12:4, pages 277-278.
Read now
Read now
N. Panay. (2009) Estrogen dose: the cardiovascular impact. Climacteric 12:sup1, pages 91-95.
Read now
Read now
M. Andrikoula & G. Prelevic. (2009) Menopausal hot flushes revisited. Climacteric 12:1, pages 3-15.
Read now
Read now
Nick Panay & Anna Fenton. (2008) HRT: does the dose matter?. Climacteric 11:3, pages 177-178.
Read now
Read now
M. H. Birkhäuser & I. Reinecke. (2008) Current trends in hormone replacement therapy: perceptions and usage. Climacteric 11:3, pages 192-200.
Read now
Read now
M. H. Birkhäuser, M. H. Birkhäuser, N. Panay, D. F. Archer, D. Barlow, H. Burger, M. Gambacciani, S. Goldstein, J. A. Pinkerton & D. W. Sturdee. (2008) Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 11:2, pages 108-123.
Read now
Read now
D. W. Sturdee, D. F. Archer, V. Rakov, E. Lang & on behalf of the CHOICE Study Investigators. (2008) Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women. Climacteric 11:1, pages 63-73.
Read now
Read now
N. Panay. (2007) New products and regimens (since 2003). Climacteric 10:sup2, pages 109-114.
Read now
Read now
D. W. Sturdee. (2007) Endometrial safety and bleeding with HRT: what's new?. Climacteric 10:sup2, pages 66-70.
Read now
Read now
E. Lundström, M. Bygdeson, G. Svane, E. Azavedo & B. von Schoultz. (2007) Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density. Climacteric 10:3, pages 249-256.
Read now
Read now
Issued on behalf of the Board of the International Menopause Society by, Amos Pines$suffix/text()$suffix/text(), David W. Sturdee$suffix/text()$suffix/text(), Martin H. Birkhäuser$suffix/text()$suffix/text(), Hermann P. G. Schneider, Marco Gambacciani & Nick Panay. (2007) IMS Updated Recommendations on postmenopausal hormone therapy. Climacteric 10:3, pages 181-194.
Read now
Read now
Articles from other publishers (41)
Abigail C WrightFrancesca L BeaudoinR. Brett McQueenKai YeungAshton MoradiSerina Herron-SmithEric GutierrezGrace A LinSteven D Pearson. (2023) The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council. Journal of Managed Care & Specialty Pharmacy 29:6, pages 692-698.
Crossref
Crossref
Lucia Costa-Paiva, Maria Celeste O Wender, Rogerio B Machado, Luciano M Pompei, Eliana A Nahas, Jorge Nahas-Neto, Sonia Y Del Debbio, Mariangela Badalotti & Achilles M Cruz. (2022) Effects of ultra-low dose hormone therapy on biochemical bone turnover markers in postmenopausal women: A randomized, placebo-controlled, double-blind trial. Post Reproductive Health 28:3, pages 149-157.
Crossref
Crossref
Andrea R Genazzani, Patrizia Monteleone, Andrea Giannini & Tommaso Simoncini. (2021) Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice. Human Reproduction Update 27:6, pages 1115-1150.
Crossref
Crossref
Haitham Hamoda, Nick Panay, Hugo Pedder, Roopen Arya & Mike Savvas. (2020) The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reproductive Health 26:4, pages 181-209.
Crossref
Crossref
S Iliodromiti, W Wang, MA Lumsden, MS Hunter, R Bell, G Mishra & M Hickey. (2019) Variation in menopausal vasomotor symptoms outcomes in clinical trials: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology 127:3, pages 320-333.
Crossref
Crossref
Sa Ra LeeMoon Kyoung ChoYeon Jean ChoSungwook ChunSeung-Hwa HongKyu Ri HwangGyun-Ho JeonJong Kil JooSeul Ki KimDong Ock LeeDong-Yun LeeEun Sil LeeJae Yen SongKyong Wook YiBo Hyon YunJung-Ho ShinHee Dong Chae & Tak Kim. (2020) The 2020 Menopausal Hormone Therapy Guidelines. Journal of Menopausal Medicine 26:2, pages 69.
Crossref
Crossref
Ayesha A. Javed, Alexandra J. Mayhew, Alison K. Shea & Parminder Raina. (2019) Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women. JAMA Network Open 2:8, pages e1910154.
Crossref
Crossref
Sven O. Skouby. 2019. Sex Steroids' Effects on Brain, Heart and Vessels. Sex Steroids' Effects on Brain, Heart and Vessels
275
285
.
Nick Panay. 2018. Dewhurst's Textbook of Obstetrics & Gynaecology. Dewhurst's Textbook of Obstetrics & Gynaecology
672
688
.
A. A. Smetnik. (2017) MENOPAUSAL HORMONE THERAPY WITH DYDROGESTERONE: ASPECTS OF EFFICACY AND SAFETY OF ULTRA-LOW DOSES. Medical Council:2, pages 92-99.
Crossref
Crossref
G Sarri, H Pedder, S Dias, Y Guo & MA Lumsden. (2017) Vasomotor symptoms resulting from natural menopause: a systematic review and network meta‐analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause. BJOG: An International Journal of Obstetrics & Gynaecology 124:10, pages 1514-1523.
Crossref
Crossref
Ana Marcia IS Gaudard, Sulani Silva de Souza, Maria ES Puga, Jane Marjoribanks, Edina MK da Silva & Maria R Torloni. (2016) Bioidentical hormones for women with vasomotor symptoms. Cochrane Database of Systematic Reviews 2016:8.
Crossref
Crossref
Georgina E. Hale & Chrisandra L. Shufelt. (2015) Hormone therapy in menopause: An update on cardiovascular disease considerations. Trends in Cardiovascular Medicine 25:6, pages 540-549.
Crossref
Crossref
Lujin Li, Yinghua Lv, Ling Xu & Qingshan Zheng. (2015) Quantitative efficacy of soy isoflavones on menopausal hot flashes. British Journal of Clinical Pharmacology 79:4, pages 593-604.
Crossref
Crossref
Kristine E. Ensrud, Katherine A. Guthrie, Chancellor Hohensee, Bette Caan, Janet S. Carpenter, Ellen W. Freeman, Andrea Z. LaCroix, Carol A. Landis, JoAnn Manson, Katherine M. Newton, Julie Otte, Susan D. Reed, Jan L. Shifren, Barbara Sternfeld, Nancy F. Woods & Hadine Joffe. (2015) Effects of Estradiol and Venlafaxine on Insomnia Symptoms and Sleep Quality in Women with Hot Flashes. Sleep 38:1, pages 97-108.
Crossref
Crossref
Hanna Savolainen-Peltonen, Hanna Hautamäki, Pauliina Tuomikoski, Olavi Ylikorkala & Tomi S. Mikkola. (2014) Health-related quality of life in women with or without hot flashes. Menopause 21:7, pages 732-739.
Crossref
Crossref
David F. Archer, Thomas Schmelter, Matthias Schaefers, Christoph Gerlinger & Kerstin Gude. (2014) A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women. Menopause 21:3, pages 227-235.
Crossref
Crossref
. (2014) Practice Bulletin No. 141. Obstetrics & Gynecology 123:1, pages 202-216.
Crossref
Crossref
Nick Panay, Haitham Hamoda, Roopen Arya & Michael Savvas. (2013) The 2013 British Menopause Society & Women’s Health Concern recommendations on hormone replacement therapy. Menopause International 19:2, pages 59-68.
Crossref
Crossref
Nick Panay. (2012) Commentary regarding recent Million Women Study critique and subsequent publicity. Menopause International 18:1, pages 33-35.
Crossref
Crossref
Nick Panay. 2012. Dewhurst's Textbook of Obstetrics & Gynaecology. Dewhurst's Textbook of Obstetrics & Gynaecology
553
564
.
María‐del‐Carmen Cravioto, Marta Durand‐Carbajal, Luisa Jiménez‐Santana, Pilar Lara‐Reyes, Armando H. Seuc & Jorge Sánchez‐Guerrero. (2011) Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: A randomized, double‐blind, controlled trial. Arthritis Care & Research 63:12, pages 1654-1663.
Crossref
Crossref
I. Wiegratz. (2011) Ultraniedrig dosierte HormonersatztherapieUltralow-dose hormone replacement therapy. Gynäkologische Endokrinologie 9:3, pages 165-170.
Crossref
Crossref
John C. Stevenson, Gemma Durand, Elke Kahler & Tomasz Perty?ski. (2010) Oral ultra-low dose continuous combined hormone replacement therapy with 0.5mg 17?-oestradiol and 2.5mg dydrogesterone for the treatment of vasomotor symptoms: Results from a double-blind, controlled study. Maturitas 67:3, pages 227-232.
Crossref
Crossref
Mette H. Moen, Margaret Rees, Marc Brincat, Tamer Erel, Marco Gambacciani, Irene Lambrinoudaki, Karin Schenck-Gustafsson, Florence Tremollieres, Svetlana Vujovic & Serge Rozenberg. (2010) EMAS position statement: Managing the menopause in women with a past history of endometriosis. Maturitas 67:1, pages 94-97.
Crossref
Crossref
David F. Archer. (2010) Tissue-Selective Estrogen Complexes. Drugs & Aging 27:7, pages 533-544.
Crossref
Crossref
C. Bergeron, F.F. Nogales, T. Rechberger, T. Tatarchjuk & L. Zipfel. (2010) Ultra low dose continuous combined hormone replacement therapy with 0.5mg 17β-oestradiol and 2.5mg dydrogesterone: Protection of the endometrium and amenorrhoea rate. Maturitas 66:2, pages 201-205.
Crossref
Crossref
Jeong Yuen KimJae Hong SangHyoung Moo Park. (2010) The change of hormone therapy in postmenopausal women in Korea before and after women's health initiative study: 2000~2009. Korean Journal of Obstetrics and Gynecology 53:12, pages 1110.
Crossref
Crossref
Pauliina Tuomikoski, Tomi S. Mikkola, Esa Hämäläinen, Matti J. Tikkanen, Ursula Turpeinen & Olavi Ylikorkala. (2010) Biochemical markers for cardiovascular disease in recently postmenopausal women with or without hot flashes. Menopause 17:1, pages 145-151.
Crossref
Crossref
Pauliina Tuomikoski, Pia Ebert, Per-Henrik Groop, Petri Haapalahti, Hanna Hautamäki, Mats Rönnback, Olavi Ylikorkala & Tomi S. Mikkola. (2009) Effect of Hot Flushes on Vascular Function. Obstetrics & Gynecology 114:4, pages 777-785.
Crossref
Crossref
S Daayana & C M Holland. (2009) Hormone replacement therapy and the endometrium. Menopause International 15:3, pages 134-138.
Crossref
Crossref
Andrea R. Genazzani & Nicola Pluchino. (2009) Menopausal hot flashes. Menopause 16:5, pages 851-853.
Crossref
Crossref
Amnon Brzezinski & Abraham Benshushan. (2009) Estrogen for vulvovaginal symptoms. Menopause 16:5, pages 848-850.
Crossref
Crossref
JoAnn V PinkertonDale W StovallRebecca S Kightlinger. (2009) Advances in the Treatment of Menopausal Symptoms. Women's Health 5:4, pages 361-384.
Crossref
Crossref
Pauliina Tuomikoski, Pia Ebert, Per-Henrik Groop, Petri Haapalahti, Hanna Hautamäki, Mats Rönnback, Olavi Ylikorkala & Tomi S. Mikkola. (2009) Evidence for a Role of Hot Flushes in Vascular Function in Recently Postmenopausal Women. Obstetrics & Gynecology 113:4, pages 902-908.
Crossref
Crossref
Ilona Hasper, Boris M. Ventskovskiy, Reinhard Rettenberger, Peter W. Heger, David S. Riley & Marietta Kaszkin-Bettag. (2009) Long-term efficacy and safety of the special extract ERr 731 of Rheum rhaponticum in perimenopausal women with menopausal symptoms. Menopause 16:1, pages 117-131.
Crossref
Crossref
U. Gaspard. (2008) Prévention des troubles coronaires par le traitement hormonal précoce à la ménopause : une idée qui s’impose à nouveau. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 37:4, pages 340-345.
Crossref
Crossref
Odd Erik Johansen & Erik Qvigstad. (2008) Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg. Advances in Therapy 25:6, pages 525-551.
Crossref
Crossref
David W. Sturdee. (2008) The menopausal hot flush—Anything new?. Maturitas 60:1, pages 42-49.
Crossref
Crossref
David H. Barlow. (2008)
The Medical Management of Menopause
. Annals of the New York Academy of Sciences 1127:1, pages 134-139.
Crossref
Crossref
David Morris. (2007) The benefits and risks of prescribing HRT. Independent Nurse 2007:8.
Crossref
Crossref